InsidersTradesSigma
Total declarations
Companies
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Explore the full record of transactions filed by Schaub James, Dirigeant. Insider active across 3 companies, notably Osmotica Pharmaceuticals plc. Aggregated, 7 reports have been published. Total volume traded: €178k. The latest transaction was disclosed on 18 May 2022 — Retenue fiscale. Regulator: SEC (Form 4). All data is openly available.
Declarations7 total
€8,3866,273 shares@ €1.336830.5% of flow
Ordinary Shares
SEC:0001104659-22-063391:0·
€9,5729,607 shares@ €0.996334.8% of flow
Ordinary Shares
SEC:0001104659-22-007838:0·
€9,5729,607 shares@ €0.9963100.0% of flow
Ordinary Shares
SEC:0001104659-22-007838·
€88,89293,800 shares@ €0.947784.0% of flow
Ordinary Shares
SEC:0001104659-21-151769·
Ideal exit: 12 Sept 2022 (T+270)
€88,89293,800 shares@ €0.947784.0% of flow
Ordinary Shares
SEC:0001104659-21-151769:0·
Ideal exit: 12 Sept 2022 (T+270)
€16,8996,621 shares@ €2.552416.0% of flow
Ordinary Shares
SEC:0001104659-21-069884·
€16,8996,621 shares@ €2.552416.0% of flow
Ordinary Shares
SEC:0001104659-21-069884:0·
7 of 7 declarations
About Schaub James
James Schaub is the Executive Vice President and Chief Operating Officer at Osmotica Pharmaceuticals plc. In this role, he oversees the strategic operations and overall direction of the company. Schaub brings valuable expertise in operations management, contributing to optimizing Osmotica's performance. His leadership is essential for achieving the company's operational objectives.
